AP9801350A0 - Parasitical formulations. - Google Patents
Parasitical formulations.Info
- Publication number
- AP9801350A0 AP9801350A0 APAP/P/1998/001350A AP9801350A AP9801350A0 AP 9801350 A0 AP9801350 A0 AP 9801350A0 AP 9801350 A AP9801350 A AP 9801350A AP 9801350 A0 AP9801350 A0 AP 9801350A0
- Authority
- AP
- ARIPO
- Prior art keywords
- parasitical
- formulations
- administer
- convenient
- protection against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Abstract
The invention provides a solid implant comprising at least one parasiticidal compound having low aqueous solubility; and tabletting excipients including a bulking agent. Implants according to the invention are convenient to administer and provide prolonged protection against parasites.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9720228.7A GB9720228D0 (en) | 1997-09-23 | 1997-09-23 | Parasiticidal formulations |
GBGB9810143.9A GB9810143D0 (en) | 1998-05-12 | 1998-05-12 | Parasiticidal formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
AP9801350A0 true AP9801350A0 (en) | 2000-03-17 |
Family
ID=26312302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1998/001350A AP9801350A0 (en) | 1997-09-23 | 1998-09-17 | Parasitical formulations. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1014970A1 (en) |
JP (1) | JP2001517622A (en) |
AP (1) | AP9801350A0 (en) |
AR (1) | AR013509A1 (en) |
AU (1) | AU9742298A (en) |
BR (1) | BR9812385A (en) |
CA (1) | CA2304283A1 (en) |
GT (1) | GT199800149A (en) |
MA (1) | MA24655A1 (en) |
PA (1) | PA8459501A1 (en) |
PE (1) | PE117199A1 (en) |
TN (1) | TNSN98175A1 (en) |
WO (1) | WO1999015166A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
US6645192B2 (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
AU1556000A (en) * | 1999-11-22 | 2001-06-04 | Akzo Nobel N.V. | Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
US6953586B1 (en) | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
DE10032878A1 (en) * | 2000-07-06 | 2002-01-17 | Bayer Ag | Anthelmintics to prevent parasitic infections in humans and animals |
AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
US7918863B2 (en) | 2005-06-24 | 2011-04-05 | Conceptus, Inc. | Minimally invasive surgical stabilization devices and methods |
US20200179273A1 (en) * | 2017-06-06 | 2020-06-11 | Merck Sharp & DohmeCorp | Long-action implant for treatment of infectious diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240274A3 (en) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectins as growth promotant agents |
US4847243A (en) * | 1987-10-08 | 1989-07-11 | Merck & Co., Inc. | Treatment for fescue toxicosis in grazing animals |
NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
-
1998
- 1998-09-04 WO PCT/EP1998/005720 patent/WO1999015166A1/en not_active Application Discontinuation
- 1998-09-04 BR BR9812385-8A patent/BR9812385A/en not_active IP Right Cessation
- 1998-09-04 JP JP2000512535A patent/JP2001517622A/en active Pending
- 1998-09-04 AU AU97422/98A patent/AU9742298A/en not_active Abandoned
- 1998-09-04 CA CA002304283A patent/CA2304283A1/en not_active Abandoned
- 1998-09-04 EP EP98951367A patent/EP1014970A1/en not_active Withdrawn
- 1998-09-17 PA PA19988459501A patent/PA8459501A1/en unknown
- 1998-09-17 AP APAP/P/1998/001350A patent/AP9801350A0/en unknown
- 1998-09-21 AR ARP980104712A patent/AR013509A1/en unknown
- 1998-09-22 MA MA25268A patent/MA24655A1/en unknown
- 1998-09-22 TN TNTNSN98175A patent/TNSN98175A1/en unknown
- 1998-09-22 PE PE1998000903A patent/PE117199A1/en not_active Application Discontinuation
- 1998-09-22 GT GT199800149A patent/GT199800149A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PA8459501A1 (en) | 2000-05-24 |
BR9812385A (en) | 2000-09-12 |
WO1999015166A1 (en) | 1999-04-01 |
CA2304283A1 (en) | 1999-04-01 |
AR013509A1 (en) | 2000-12-27 |
MA24655A1 (en) | 1999-04-01 |
PE117199A1 (en) | 1999-11-20 |
TNSN98175A1 (en) | 2005-03-15 |
GT199800149A (en) | 2000-03-15 |
EP1014970A1 (en) | 2000-07-05 |
JP2001517622A (en) | 2001-10-09 |
AU9742298A (en) | 1999-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000041681A3 (en) | MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST | |
MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
AU2000279625A1 (en) | Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient | |
HK1034183A1 (en) | Galenic formulations of meloxicam for oral administration. | |
BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
AU1276501A (en) | Active ingredient combination having insecticidal and acaricidal characteristics | |
BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
IL153297A0 (en) | Compounds and compositions for delivering active agents | |
HK1024182A1 (en) | Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations | |
ZA200003121B (en) | Flash-melt oral dose formulations. | |
CA2339765A1 (en) | Compounds and compositions for delivering active agents | |
MXPA01008611A (en) | Compounds and compositions for delivering active agents. | |
GB0025173D0 (en) | Therapeutic agents | |
IL133397A0 (en) | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
SE0102843D0 (en) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
IL146025A0 (en) | Improved pharmaceutical formulations comprising at least one hiv protease inhibiting compound | |
AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
AP9801350A0 (en) | Parasitical formulations. | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
NO994431L (en) | New wording | |
GB9907571D0 (en) | Compounds | |
ZA200201807B (en) | Active ingredient combinations having insecticidal and acaricidal properties. | |
EP1328236A4 (en) | Methods of decreasing or preventing pain using spicamycin derivatives |